Prosecution Insights
Prosecution Insights
Tech Center 3700 • Art Units: 1617 1645 3774
This examiner grants 56% of resolved cases
Michael B. Pallay is assigned to Art Unit 1617 within Tech Center 3700. The examiner has a record of 739 resolved cases and an allowance rate of 55.9 percent. This rate suggests that prosecution in this unit requires careful navigation, as nearly half of the cases do not reach allowance. The median days to allowance is 1164, providing a benchmark for the expected duration of the patent acquisition process. These statistics are based on a large sample of 739 cases, making them a robust foundation for predicting future outcomes in Art Unit 1617.
The interview lift is notably high at 33.9 percent. This figure is particularly significant when compared to the 55.9 percent allowance rate, as it indicates that interviews are exceptionally effective at moving cases toward a grant. For practitioners, this 33.9 percent lift suggests that an interview should be a standard part of the prosecution strategy. The 1164-day median pendency may be more effectively managed by utilizing this high lift to resolve technical or legal issues early. The data from 739 cases underscores the importance of direct engagement with this examiner.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17996084 | METHODS OF DECREASING MUSCLE ATROPHY AND/OR PROMOTING MUSCLE REGENERATION | Final Rejection | ABBOTT LABORATORIES |
| 18563543 | HYDROLYTICALLY DEGRADABLE HYDROGELS AND USES THEREOF | Non-Final OA | GEORGIA TECH RESEARCH CORPORATION |
| 19049120 | LOW VISCOSITY CONDITIONER COMPOSITION CONTAINING SILICONE POLYMERS | Non-Final OA | The Procter & Gamble Company |
| 17126932 | SUPERIOR EFFICACY OF AZOXYSTROBIN AND OTHER STROBILURINS | Final Rejection | The Procter & Gamble Company |
| 18734329 | SOLID FORMULATIONS COMPRISING AN INHIBITOR OF THE K-RAS PROTEIN HAVING A G12C MUTATION, AND A PROCESS FOR PREPARING | Non-Final OA | GENENTECH, INC. |
| 18797592 | SUNSCREEN OR DAILY CARE COMPOSITION COMPRISING BIS-ETHYLHEXYLOXYPHENOL METHOXYPHENYL TRIAZINE | Non-Final OA | BASF SE |
| 17793755 | NOVEL ADDITIVES FOR AGROCHEMICAL FORMULATIONS | Final Rejection | BASF SE |
| 17624161 | SELECTIVE WEED CONTROL | Non-Final OA | SYNGENTA CROP PROTECTION AG |
| 18312757 | Pet Food Compositions | Final Rejection | Hill's Pet Nutrition, Inc. |
| 18012299 | COMPOSITIONS, PROCESSES, AND KITS FOR SIMULTANEOUS BLEACHING AND DYEING OF KERATIN FIBERS | Final Rejection | L'Oreal |
| 18644608 | MEK1/2 INHIBITOR-LOADED MICROPARTICLE FORMULATION | Final Rejection | The United States Government, as Represented by the Department of Veterans Affairs |
| 18992363 | OIL-IN-WATER EMULSION-TYPE COSMETIC COMPOSITION | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18874772 | WATER-IN-OIL EMULSIFIED SOLID COSMETIC | Non-Final OA | SHISEIDO COMPANY, LTD. |
| 18951152 | Oral Care Compositions | Non-Final OA | Colgate-Palmolive Company |
| 17627221 | HERBICIDAL COMPOSITION CONTAINING R-TYPE PYRIDYLOXY CARBOXYLIC ACID DERIVATIVE AND USE THEREOF | Non-Final OA | Qingdao Kingagroot Chemical Compound Co., Ltd. |
| 19028767 | ADIPOSE TISSUE MATRICES | Non-Final OA | LifeCell Corporation |
| 18579096 | TARGETED GLYCOSAMINOGLYCAN-PARTICLES AND METHODS OF USE | Final Rejection | The Board of Regents of the University of Oklahoma |
| 17195819 | PIGMENT COMPOSITION FOR SEED COATINGS | Non-Final OA | Sun Chemical Corporation |
| 18740160 | COMPARTMENTED PHARMACEUTICAL DOSAGE FORMS | Non-Final OA | Triastek, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy